Cost of Illness Study in Thyroid Patients: A Systematic Review
Downloads
Background: The thyroid has a vital role in growth, neurodevelopment, reproduction, and metabolism. About 300 million people around the world had been reported to be suffering from thyroid disorders, but more than half were unaware. The factors of sex, age, weight of disease, and other accompanying conditions should be considered, otherwise, it will cause a long time treatment period in which the cost will become higher from year to year. Purpose: The systematic review aims to provide an overview of the financial burden caused by thyroid disease for the communities, governments and health care providers. Method: A systematic review of publications in several databases, namely PUBMED, SCIENCE DIRECT, DOAJ, SCOPUS and GOOGLE SCHOLAR. Results: Six research articles were obtained from publications selected for systematic review. The reviewed articles show overviews of the cost of thyroid disease in several countries. The financial burden of thyroid patients in some countries varies, with different perspectives. The lowest to highest cost ranges from 0.125 USD/patient – 8106 USD/patient. Conclusion: The study in this review illustrates the various costs in different countries; the cost of screening, and thyroid surgery has the largest contribution compared to other costs; research on the financial burden suffered by thyroid patients in the future must be carried out continuously and periodically to be able to estimate the cost of therapy more appropriately to provide a useful data for health care providers, governments and the community. Direct medical costs are the largest proportion.
Awad, S. A. S., Ashraf, E. M., Khaled, A. S., Salih, B. S., Yousef, S., Abeer, A. S., & Anna, A. (2016).
The epidemiology of thyroid diseases in the Arab world: A systematic review. Journal of Public Health and Epidemiology, 8(2), 17–26. https://doi.org/10.5897/jphe2015.0713
Bang, K., Watt, T., & Hegedüs, L. (2014). Anxiety and Depression Are More Prevalent in Patients with Graves' Disease. 173–178. https://doi.org/10.1159/000365211
Endocrine Society. (2015). Endocrine Facts and Figures First Edition Thyroid.
Filetti, S., Durante, C., Hartl, D., Leboulleux, S., Locati, L. D., Newbold, K., Papotti, M. G., & Berruti, A. (2019). Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 30(12), 1856–1883. https://doi.org/10.1093/annonc/mdz400
Finnerty, B. M., Brunaud, L., Mirallie, E., & Mcintyre, C. (2014). Cost disparity between health care systems ” it ' s not the surgeons : A cost analysis of thyroid cancer care between the United States and France. Surgery, 159(1), 132–141. https://doi.org/10.1016/j.surg.2015.06.049
Hepp, Z., Lage, M. J., Espaillat, R., & Gossain, V. V. (2021). The direct and indirect economic burden of hypothyroidism in the United States: a retrospective claims database study. Journal of Medical Economics, 24(1), 440–446. https://doi.org/10.1080/13696998.2021.1900202
Hollenbeak, C. S., Lendel, I., Beus, K. S., Ruda, J. M., & Stack, B. C. J. (2007). The cost of screening for synchronous thyroid disease in patients presenting with primary hyperparathyroidism. Archives of Otolaryngology--Head & Neck Surgery, 133(10), 1013–1021. https://doi.org/10.1001/archotol.133.10.1013
Hyun, K. R., Kang, S., & Lee, S. (2014). Cost-of-illness trends associated with thyroid disease in Korea. Endocrinology and Metabolism, 29(3), 257–269. https://doi.org/10.3803/EnM.2014.29.3.257
Indonesian Thyroid Association. (2022). KAPITA SELEKTA TIROID edisi 1.
Ioachimescu, A. G. (2019). Thyroid Cancer. Endocrinology and Metabolism Clinics of North America, 48(1), xv–xvi. https://doi.org/10.1016/j.ecl.2018.12.002
Jo, C. (2014). Cost-of-illness studies: concepts, scopes, and methods. Clinical and Molecular Hepatology, 20(4), 327–337. https://doi.org/10.3350/cmh.2014.20.4.327
Kahaly, G. J., & Dietlein, M. (2002). Cost estimation of thyroid disorders in Germany. Thyroid : Official Journal of the American Thyroid Association, 12(10), 909–914. https://doi.org/10.1089/105072502761016548
Kant, R., Davis, A., & Verma, V. (2020). Thyroid nodules: Advances in evaluation and management. American Family Physician, 102(5), 297–304. http://dx.doi.org/
Kim, S. Y., Kim, S. M., Chang, H., Kim, B. W., Lee, Y. S., Kwon, S. S., Shin, H., Chang, H. S., & Park, C. S. (2019). Cost for treatment and follow-up of thyroid cancer increases according to the severity of disease. Head and Neck, 41(7), 2376–2379. https://doi.org/10.1002/hed.25706
Leko, M. B., GunjaÄa, I., Pleić, N., & Zemunik, T. (2021). Environmental factors affecting thyroid-stimulating hormone and thyroid hormone levels. International Journal of Molecular Sciences, 22(12). https://doi.org/10.3390/ijms22126521
Mí¸llehave, L. T., Linneberg, A., Skaaby, T., Knudsen, N., Ehlers, L., Jí¸rgensen, T., & Thuesen, B. H. (2018). Trends in Costs of Thyroid Disease Treatment in Denmark during 1995-2015. European Thyroid Journal, 7(2), 75–83. https://doi.org/10.1159/000485973
National Institute for Health and Care Excellence. (2019). Thyroid disease: assessment and management. National Institute for Health and Care Excellence Guideline, November 2019, 1–55. https://www.nice.org.uk/guidance/ng145/resources/thyroid-disease-assessment-and-management-pdf-66141781496773
Patty, Yohana Febriani Putri Peu, Mufarrihah, and Nita, Yunita. "Cost of illness of diabetes mellitus in Indonesia: a systematic review" Journal of Basic and Clinical Physiology and Pharmacology, vol. 32, no. 4, 2021, pp. 285-295. https://doi.org/10.1515/jbcpp-2020-0502
Saharah, S., Lorensia, A., & Suyanto, S. (2020). Analysis of Real Costs and INA-CBG of Hyperthyroidism in Hasanuddin University Hospital. Media Kesehatan Masyarakat Indonesia, 16, 421–429. https://doi.org/10.30597/mkmi.v16i4.10990
Taylor, P. N., Albrecht, D., Scholz, A., Gutierrez-Buey, G., Lazarus, J. H., Dayan, C. M., & Okosieme, O. E. (2018). Global epidemiology of hyperthyroidism and hypothyroidism. Nature Reviews Endocrinology, 14(5), 301–316. https://doi.org/10.1038/nrendo.2018.18
Zimmermann, M. B., & Andersson, M. (2021). Global perspectives in endocrinology: Coverage of iodized salt programs and iodine status in 2020. European Journal of Endocrinology, 185(1), R13–R21. https://doi.org/10.1530/EJE-21-0171.
Copyright (c) 2023 JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
1. The copyright of this journal belongs to the Editorial Board and Journal Manager with the author's knowledge, while the moral right of the publication belong to the author.
2. The formal legal aspect of journal publication accessibility refers to the Creative Commons Attribution-Non-Commercial-Share Alike (CC BY-NC-SA), which implies that the publication can be used for non-commercial purposes in its original form.
3. Every publication (print/electronic) is open access for educational, research, and library purposes. In addition to the objectives mentioned above, the editorial board is not responsible for copyright infringement
.jpg)
